Prediction: Eli Lilly Will Be Worth $2 Trillion by 2031

Eli Lilly (NYSE: LLY) made history last year when it became the first healthcare stock to hit a $1 trillion market cap. It hasn't performed that well since, due to a combination of factors, including questions about its valuation. However, the company is riding a powerful tailwind that could allow it to become a $2 trillion corporation in five years, nearly doubling from its current levels. Here is why the stock is a buy.Image source: The Motley Fool.Over the past three years, Eli Lilly's revenue growth has been more comparable to that of a smaller tech corporation than to that of a major pharmaceutical giant. Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool